Regenerex Pharma, Inc. provides advanced wound care solutions and products, including specialized sterile wound creams like Xcellderma and Accelerex, designed to treat chronic and acute wounds such as diabetic foot ulcers, pressure ulcers, and burns. The company serves healthcare systems, managed care organizations, and federal agencies by offering turnkey wound closure programs and patented technology aimed at improving healing outcomes and managing treatment costs.
Subscribe to see REGENEREX PHARMA, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
REGENEREX PHARMA, INC. is a pharmaceuticals company headquartered in United States. Xcout tracks 3 named people at REGENEREX PHARMA, INC., including Gregory P. Pilant (Chairman of the Board).
A few of REGENEREX PHARMA, INC.'s closest competitors — see the full list of competitors and alternatives →
Nexsis Biosciences LLC distributes advanced tissue-repair products and biomaterials derived from porcine small intestinal submucosa (SIS) for surgical and wound management applications. The company serves healthcare providers and patients by offering extracellular matrix (ECM) devices that support site-specific tissue remodeling and healing without leaving permanent material behind.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
iMed Technology, Inc. is a US-based medical device manufacturer and business entity headquartered in Texas, specializing in single-use wound care and clinical products.
Mölnlycke Health Care is a medical technology company that provides innovative wound care and surgical solutions for patients and healthcare professionals. The company serves hospitals, clinicians, and patients by offering products such as foam dressings, antiseptic products, and surgical environment supplies designed to improve care efficiency and clinical outcomes.
Medical Grade Innovations provides tailored solutions and products to healthcare facilities and communities to help minimize the spread of contagion and manage employees and patients. Their offerings include the WellFocused System for public health management and specialized medical-grade garments such as antimicrobial, moisture-wicking scrubs.
Gerry Care, Inc. manufactures and distributes over-the-counter medications, vitamins, supplements, creams, and medical devices. The company provides private label manufacturing, wholesale supply, and distribution services to retailers, long-term care providers, government programs, and health systems across the United States.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.